After Sinovac, AstraZeneca and Sinopharm, now BPOM publishes EUA Moderna Vaccine

Tribunnews Reporter, Fitri Wulandari

TRIBUNNEWS.COM, JAKARTA – The Food and Drug Supervisory Agency (BPOM) has just issued an emergency use authorization or Emergency Use Authorization (EUA) for the Moderna coronavirus (Covid-19) vaccine.

Head of BPOM Penny Kusumastuti Lukito said that his party had issued an EUA for the vaccine produced by the United States (US) pharmaceutical and biotechnology company, Moderna, Inc.

“Yesterday we added one more type of Covid-19 vaccine that has received Emergency Use Authorization from the POM, namely the Moderna Covid-19 Vaccine,” said Penny, in a virtual press conference entitled ‘EUA Moderna Covid-19 Vaccine’, Friday (2/02/2011). 7/2021).

Also read: India Approves Moderna Vaccine for Emergency Use

Also read: Vaccination is running, Ex Minister of Health Siti Fadilah questions the cause of the Covid-19 death spike

Please note, this is the first time BPOM has issued an EUA for a Covid-19 vaccine that uses the mRNA platform.

This vaccine is also obtained through multilateral channels, namely the COVAX facility initiated by the World Health Organization (WHO) and several other alliances.

“For this time, I think the vaccine will enter through the bilateral route, aid from America which is channeled through the multilateral, namely the COVAX facility,” said Penny.

He then explained that this vaccine is safe to use in the age group of 18 years and over.

Also read: Japanese Minister Suspends Mass Registration of Covid-19 Vaccination, Waits for Moderna Vaccine Arrival

Also read: Moderna Vaccine Will Also Be Provided To All Cities in Japan

“This Moderna vaccine is an mRNA vaccine with indications for use for immunization in the context of preventing Covid-19 caused by SARS-CoV-2 for people aged 18 years and over,” explained Penny.

Vaccination using this vaccine is done through 2 times intramuscular injection with a dose of 0.5 ml.

Meanwhile, the time span between the administration of the first dose to the second dose is 1 month.

“Given by intramuscular injection, a dose of 0.5 ml with 2 injections, with a span of one month,” said Penny.

Previously, until last June, BPOM had issued EUA for 4 types of Covid-19 vaccines, namely Coronavac from Sinovac Life Sciences Co., Ltd, then Covid-19 vaccine produced by state-owned pharmaceutical company PT Bio Farma from ‘bulk’ which obtained from Sinovac.

Then AstraZeneca which is produced by the COVAX facility, and Sinopharm which is obtained from Beijing Bio-Institute Biological Products Co Ltd.

–